USA 110 , 52115216 (2013)
Therapeutic strategies for targeting ferroptosis It has been over a decade since the term ferroptosis was first introduced, and as research has advanced, several clinical drugs and bioactive pharmacological agents have been identified as modulators of ferroptosis, including inhibitors (Table 2) [113,114,115,116,117,118,119,120,121,122,123,124,125] and inducers (Table 3) [126,127,128,129,130,131,132,133,134,135,136,137,138,139,140]
Human umbilical cord mesenchymal stem cell-derived exosomes provide neuroprotection in traumatic brain injury through the LncRNA TUBB6/Nrf2 pathway
Large-scale RCTs are ongoing to validate its long-term efficacy, impact on functional outcomes, and prognostic benefits 84